Atara Biotherapeutics, Inc.·4

Mar 6, 6:49 PM ET

Touchon Pascal 4

4 · Atara Biotherapeutics, Inc. · Filed Mar 6, 2023

Insider Transaction Report

Form 4
Period: 2023-03-02
Transactions
  • Sale

    Common Stock

    2023-03-02$3.63/sh15,679$56,868750,728 total
Footnotes (2)
  • [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
  • [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2023 and March 3, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4